Latest Breaking News On - Company on twitter cannabics - Page 6 : comparemela.com

Cannabics Pharmaceuticals Launches Psilocybin and Psilocin Research Program USA - English Share this article Share this article TEL AVIV, Israel and BETHESDA, Md., April 20, 2021 /PRNewswire/ Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the launching of a new research program using Psylocibin and Psilocin. The announcement comes after the company was able to obtain a license from the Israeli Ministry of Health to conduct scientific research using Psylocibin and Psilocin in the company s in-house laboratory facilities in Rehovot, Israel. Eyal Barad, Cannabics Pharmaceuticals co-founder and CEO said: We see the growing interest in psychedelic-based drug development, and we understand the potential of psychedelic-based medicine. We also believe that given our knowhow, experience and state of the art in-house drug discovery platform, we are well positioned to take advantage of th

Facebook cannabicspharmaceuticalsInstagram cannabicsEyal baradCompany on twitter cannabicsMinistry of healthExchange commissionCannabics pharmaceuticalsPrnewswire cannabics pharmaceuticals incIsraeli ministry of healthCannabics pharmaceuticals incIsraeli ministryPrivate securities litigation reform actகண் பராட்அமைச்சகம் ஆஃப் ஆரோக்கியம்பரிமாற்றம் தரகுஇஸ்ரேலி அமைச்சகம் ஆஃப் ஆரோக்கியம்